Skip to main content
 CHANGE IN VISITATION GUIDELINES: Please read before visiting Rutgers Cancer Institute.
Menu

Kevin Kelly

Kevin D. Kelly currently serves as Vice President/General Manager for Becton Dickinson’s Medication Delivery Solutions’ US business, headquartered in Franklin Lakes, NJ.  MDS is a leading supplier of IV catheters and related vascular care and preparation products used across the vascular access spectrum. MDS is also a market leader in injection systems, anesthesia, and oncology therapy delivery products.

Kevin was previously President, Corporate Healthcare Services for C.R. Bard in Murray Hill, NJ, responsible for Bard’s IDN account management, GPO and Distributor contracts, Sales Operations, and Corporate Marketing.  He joined Bard (now BD) in 2010 as Vice President of Sales, Bard Electrophysiology Division and was promoted to Vice President/General Manager. 

Formerly, Kevin held positions in commercial leadership, market development and operations in such early stage medical device companies as Smartpill Corporation (now Medtronic), LeMaitre Vascular (LMAT) and MedSource Technologies (now Integer).  He played an instrumental role in taking both LeMaitre and MedSource public in 2006 and 2002 respectively. 

Kevin is an active member of Director’s Leadership Council at Rutgers Cancer Institute of New Jersey. He is also a member of Board of Trustees for the Cancer Support Community of Central New Jersey. 

Kevin earned his Master of Business Administration degree from the Harvard Business School, and Bachelor of Science and Master of Science degrees in Civil Engineering from Tufts University.